Showing results (111-120 of 198) with videos related to

Sort By:
Pageof 20
Oncogene|August 2, 2025
PKA-driven SPP1 activation as a novel mechanism connecting the bone microenvironment to prostate cancer progressionPablo Sanchis, Agustina Sabater, Julia Lechuga, et al.
The American Journal of Pathology|January 17, 2012
Integrative molecular profiling reveals asparagine synthetase is a target in castration-resistant prostate cancerKanishka Sircar, Heng Huang, Limei Hu, et al.
Convergent Science Physical Oncology|March 26, 2019
Multiplex protein detection on circulating tumor cells from liquid biopsies using imaging mass cytometryErik Gerdtsson, Milind Pore, Jana-Aletta Thiele, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2009
Phase II presurgical feasibility study of bevacizumab in untreated patients with metastatic renal cell carcinomaEric Jonasch, Christopher G Wood, Surena F Matin, et al.
Radiology|January 25, 2022
Defining Diagnostic Criteria for Prostatic Ductal Adenocarcinoma at Multiparametric MRIWeranja K B Ranasinghe, Patricia Troncoso, Devaki Shilpa Surasi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 5, 2026
Prostate-Specific Membrane Antigen Radioligand Therapy in Patients with Aggressive-Variant Prostate CancerMoein Moradpour, Abuzar Moradi Tuchayi, Surekha Yadav, et al.
Urology|January 4, 2020
Determining Clinically Based Factors Associated With Reclassification in the Pre-MRI Era using a Large Prospective Active Surveillance CohortJustin R Gregg, John W Davis, Chad Reichard, et al.
Nature Communications|March 17, 2017
H3 ubiquitination by NEDD4 regulates H3 acetylation and tumorigenesisXian Zhang, Binkui Li, Abdol Hossein Rezaeian, et al.
The American Journal of Gastroenterology|November 24, 2021
A 2-Step Strategy Combining FIB-4 With Transient Elastography and Ultrasound Predicted Liver Cancer After HCV CureJavier Ampuero, Isabel Carmona, Francisca Sousa, et al.
Cancer|August 27, 2014
Randomized phase 2 study of bone-targeted therapy containing strontium-89 in advanced castrate-sensitive prostate cancerMehmet Asim Bilen, Marcella M Johnson, Paul Mathew, et al.
Pageof 20